Kimie Nakagawa 2026-11-05
Kimie Nakagawa investigated Vitamin K metabolism, including how cells make menaquinone-4. A 2010 study identified UBIAD1 as a human biosynthetic enzyme using complementary perturbation and expression experiments.[ref]
Reducing UBIAD1 expression with siRNA decreased formation of isotope-labelled menaquinone-4 in human cells. Expression in insect cells provided a second test, and deuterium nuclear magnetic resonance checked the product's identity. Combining altered production with chemical identification is stronger evidence for a biosynthetic role than similarity of protein sequences alone.[ref]
Prenyltransferase 2026-11-05
A prenyltransferase is an enzyme that transfers a prenyl group, an isoprenoid-derived carbon group, to an acceptor. The term covers multiple reactions; the acceptor can be a small molecule rather than a protein. It should therefore not be interpreted as meaning only an enzyme for protein prenylation.
One concrete reaction joins the five-carbon dimethylallyl diphosphate and five-carbon isopentenyl diphosphate to make ten-carbon geranyl diphosphate, releasing diphosphate. Carbon counting gives , while the substrate names specify the activated donors and the product structure. The official entry for this enzyme also notes poor acceptance of larger prenyl diphosphates as donors: a generic transfer label does not imply unrestricted substrate choice.[ref]
A different example links this chemistry to Vitamin K. In 2010, Kimie Nakagawa and colleagues identified UBIAD1 as an enzyme for menaquinone-4 biosynthesis. Reducing its expression suppressed conversion of deuterium-labelled vitamin-K derivatives into labelled product; expression in insect cells restored a production system, and nuclear magnetic resonance helped identify the product.[ref] Combining perturbation with chemical identification provides stronger evidence for an enzyme assignment than finding a similar-looking gene sequence alone.